
Oncologist

No OPD information available
Adult Soft Tissue Sarcoma
Testicular Cancer
Desmoid Tumor
Ewing Sarcoma
Fibromatosis
Orchiectomy
Osteosarcoma
Alveolar Soft Part Sarcoma
Angiosarcoma
Bone Tumor
Delayed Ejaculation
Desmoplastic Small Round Cell Tumor
Febrile Neutropenia
Heart Tumor
Hepatic Hemangioma
Lymphofollicular Hyperplasia
Melanoma
Necrosis
Retrograde Ejaculation
Rhabdomyosarcoma
Teratoma of the Mediastinum
Undifferentiated Pleomorphic Sarcoma
Urothelial Cancer
Jeremy H. Lewin is a male medical professional who helps people with different types of cancers and tumors like soft tissue sarcoma, testicular cancer, and melanoma. He also deals with conditions like delayed ejaculation and heart tumors. Jeremy has special skills to treat these illnesses and perform surgeries like orchiectomy.
Patients trust Jeremy because he communicates well with them, explaining things clearly and listening to their concerns. He stays updated with the latest medical knowledge and research to provide the best care possible. Jeremy works closely with other medical professionals, sharing knowledge and collaborating to improve patient outcomes.
Jeremy's work has positively impacted many patients' lives by helping them overcome cancer and other serious health issues. He has published important research on topics like fitness and health behaviors in cancer survivors, showing his dedication to improving patient well-being.
One of Jeremy's notable publications is a study on adolescent and young adult cancer survivors' health behaviors. He is also involved in a clinical trial evaluating a new treatment for desmoplastic small round cell tumor in pediatric patients and young adults.
Overall, Jeremy H. Lewin is a dedicated medical professional who uses his expertise to help patients fight cancer and other challenging conditions. His commitment to staying informed, collaborating with colleagues, and conducting research demonstrates his passion for improving healthcare and making a difference in people's lives.
Enrollment Status: Active not recruiting
Published: February 28, 2025
Intervention Type: Drug
Study Drug:
Study Phase: Phase 1/Phase 2
